Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

The Future of Pharmaceutical Innovation: New Challenges and Opportunities

Is the current pharmaceutical R&D model sustainable, and if not, can ‘smart regulation’ ensure that regulatory regimes are suitable for the emergent science, technologies and therapies that have the potential to transform healthcare and the industries that provide for it?

James Mittra, Joyce Tait and David Wield at the Economic and Social Research Council (ESRC) Innogen Centre (March 2011)

    View full article    |    Back to Industry Insight section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |